Rockville / Montreal / Hospital Parkville / Washington / DC / Atlanta / Lyon / London / /
Company
Luminex / USA Dr Cosette / Section of Infections International Agency / Screening Group / Vaccine Group / IARC Communications Group / IARC HPV Working Group / Section of Early Detection / Cancer Biology Group / /
Country
Switzerland / France / United States / / /
Event
FDA Phase / /
Facility
Research Institute / Genes Unit Institute of Cancer Epidemiology Danish Cancer Society Copenhagen / Health Sciences University of Tampere Tampere / Gynecology University of Helsinki Helsinki / USA Dr Maura Gillison College of Medicine The Ohio State University Columbus / Gynecology University of New Mexico / National Cancer Institute / United States National Cancer Institute / Pathology University of Cambridge Cambridge / Genetics National Cancer Institute / Laboratory Medicine / Biostatistics Karolinska Institute / United Kingdom Dr Jack Cuzick Cancer Research UK Wolfson Institute of Preventive Medicine London / Finland Dr Silvia de Sanjosé Llongueras Catalan Institute of Oncology Barcelona / University Montreal / Gynecology University of Washington Seattle / / /
IndustryTerm
Cancer Prevention / PREVENTION OF ORAL HPV INFECTION AND ASSOCIATED CANCERS / PREVENTION OF ANAL HPV INFECTION AND ANAL CANCER / /
MedicalCondition
Uterine cervical neoplasms / ANAL CANCER / HIV / SEX-BASED DIFFERENCES IN NATURAL HISTORY OF ORAL HPV INFECTION / Papillomavirus infections / squamous cell cancer / Infections / HPV ETIOLOGY OF CERVICAL VERSUS OROPHARYNGEAL CANCERS / TO ANAL CANCER / HISTOPATHOLOGICAL PROGRESSION OF CERVICAL CANCER VERSUS OROPHARYNGEAL CANCER / SEX-BASED DIFFERENCES IN INCIDENCE OF HPV-POSITIVE OROPHARYNGEAL CANCERS / Cancer / Switzerland Dr Mahboobeh Safaeian Infections / HPV VACCINES AND POTENTIAL PREVENTION OF HPV-POSITIVE HEAD AND NECK CANCER / HPV / France Dr Salvatore Vaccarella Infections / HIGH-GRADE CERVICAL DISEASE / cervical intraepithelial neoplasia / persistent infection / prior infection / France Dr Hugo De Vuyst Infections / France Dr Gary Clifford Infections / PREVENTION OF ORAL HPV INFECTION AND ASSOCIATED CANCERS / invasive cervical cancer / /
Research office of Vaccines Research / Health Sciences University of Tampere Tampere / European Medicines Agency United States Food and Drug Administration / World Health Organization Regional Office for the Americas Washington / World Health Organization / Evaluation World Health Organization Geneva / USA Dr Jorma Paavonen Department of Obstetrics / WORKING GROUP MEMBERS Dr Susanne Krüger-Kjaer Head / Virus / Lifestyle and Genes Unit Institute of Cancer Epidemiology Danish Cancer Society Copenhagen / Belgium Dr Linda Eckert Department of Obstetrics / USA Dr Margaret Stanley Department / National Center for Emerging / Sanjosé Llongueras Catalan Institute of Oncology Barcelona / Medical officer Department of Reproductive Health and Research World Health Organization Geneva / Genetics National Cancer Institute / Finland Dr Eduardo Franco Division of Cancer Epidemiology McGill / USA Dr Suzanne Garland Department of Microbiology / Belgium Medicine Commission Brussels / U.S. Food and Drug Administration Center for Biologics Evaluation / Division of Cancer Epidemiology / United States National Cancer Institute / Department of Medical Epidemiology and Biostatistics Karolinska Institute Stockholm / Centers for Disease Control and Prevention / Margaret Stanley Department / USA Dr Tiequn Zhou Medical Officer / Essential Medicines & Pharmaceutical Policies World Health Organization Geneva / Obstetrics & Gynecology University of Washington Seattle / Pathology University of Cambridge Cambridge / Department of Laboratory Medicine / Signaling and Oncogenesis Section Center for Cancer Research / USA Dr Maura Gillison College / Spain Dr Lauri Markowitz Division of STD Prevention Centers for Disease Control and Prevention Atlanta / European Medicines Agency / Canada Dr Joel Palefsky Department / WORLD HEALTH ORGANIZATION INTERNATIONAL AGENCY FOR RESEARCH ON CANCER IARC Working Group Reports Volume / Neoplastic Disease Section Deputy Laboratory Chief Center for Cancer Research / United Kingdom Dr Jack Cuzick Cancer Research UK Wolfson Institute of Preventive Medicine London / USA Dr John Schiller Center for Cancer / Research Institute Tampa / FDA / University of New Mexico / Ohio State University Columbus / Medicine UCSF School of Medicine San Francisco / Cancer Epidemiology H. Lee Moffitt Cancer Center / Obstetrics and Gynecology University of Helsinki Helsinki / United Kingdom Dr Matti Lehtinen School / Oncogenesis Section Center for Cancer Research / World Health Organization Geneva / The Ohio State University / Cancer Epidemiology & Genetics National Cancer Institute / International Agency for Research / /
Person
Ulrich Fruth Vaccine / Susan Wang / Washington Seattle / Pieter Neels / Signaling / H. Lee Moffitt / Prevention / Vivien Davis Tsu / Elizabeth R. Unger / Sholom Wacholder Biostatistics / Mark Schiffman / SEER VAIN VE VIN VLP / Salvatore Vaccarella / Allan Hildesheim / David Collingridge / Martyn Plummer / Hugo De Vuyst / Maribel Almonte / Review Silver Spring / Mahboobeh Safaeian / Gary Clifford / Jeffrey Roberts / Cervical Cancer / Nathalie Broutet / Christopher P. Wild / Paula Gonzalez / Chronic Viral / Albert Thomas / / /
Position
Investigator / Editor / The Lancet Oncology London / Rengaswamy Sankaranarayanan Head / Vice Chair / Research Head / geometric mean titre human immunodeficiency virus head / Rolando Herrero Head / HPV-POSITIVE HEAD / Franceschi Head / Professor / Douglas Lowy Head / Director / Andrea Vicari Advisor / Medical Officer / Massimo Tommasino Head / Chair / United Kingdom Dr Anna Giuliano / Associate Professor / Chief / /
WORLD HEALTH ORGANIZATION INTERNATIONAL AGENCY FOR RESEARCH ON CANCER IARC Working Group Reports Volume 7